KAZIA ENTERS CLINICAL COLLABORATION WITH CORNELL UNIVERSITY FOR PHASE II CLINICAL STUDY USING PAXALISIB IN COMBINATION WITH KETOGENIC DIET FOR GLIOBLASTOMA